Article
Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.
International journal of hematology - 1 Jun 2017
Yoshimi Akihide, Abdel-Wahab Omar
Abstract excerpt
Spliceosomal mutations, especially mutations in SF3B1, are frequently (>80%) identified in patients with refractory anemia with ringed sideroblasts (RARS) and myelodysplastic/myeloproliferative neoplasms with ringed sideroblasts and thrombocytosis (MDS/MPN-RS-T; previously known as RARS-T), and SF3B1 mutations have a high positive predictive value for disease phenotype with ringed sideroblasts. These observations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
